Results 261 to 270 of about 19,955 (310)
Some of the next articles are maybe not open access.

Reproducibility and reliability of tumor grading in urological neoplasms

World Journal of Urology, 2007
Histopathologic tumor grading reflects the degree of differentiation of a given tumor and for most urological tumors grading is an important factor in predicting their biological aggressiveness. Consequently, the clinical management of tumor patients is often strongly influenced by the tumor grade, provided by pathologists.
openaire   +2 more sources

Leiomyomata of the genitourinary tract: A case series from the “rare urological neoplasm” registry [PDF]

open access: possibleScandinavian Journal of Urology, 2012
Leiomyomata are benign neoplasms that are rarely encountered in the genitourinary tract outside the uterus. Pathological confirmation is always needed for definitive diagnosis, in order to rule out malignancies such as leiomyosarcoma. In cases of small leiomyomata, a surveillance strategy can be suggested, although the preferred approach is complete ...
ODERDA, Marco   +10 more
openaire   +3 more sources

Bile duct carcinoma following abdominal radiation for urologic neoplasms

Journal of Hepato-Biliary-Pancreatic Surgery, 1994
This report concerns three cases of bile duct carcinoma which occurred 15–40 years after patients received treatment for urogenital neoplasia. All three patients had initially received radiation therapy in addition to urological surgery. Jaundice was the major clinical symptom of the second tumor.
G. Froeschle   +4 more
openaire   +1 more source

Urologic Neoplasms: Prostate, Bladder, and Renal Cell Carcinoma

2016
This chapter illustrates clinical case examples demonstrating clinical utility and diagnostic performance of FDG PET-CT scans in prostate, bladder, and renal cell carcinoma.
Bhushan Desai, Hossein Jadvar
openaire   +1 more source

Urological second malignant neoplasms in testicular nonseminoma survivors: a population-based analysis

International Urology and Nephrology, 2020
Patients with testicular non-seminomatous germ cell tumors in the modern cisplatin-based chemotherapy era show favorable outcomes, yielding survivors exposed to increased risk of second malignant neoplasms. The carcinogenic effects of cisplatin were well established, and its side effects had shown close connections with the urinary system.
Hao Li   +7 more
openaire   +2 more sources

[Course of cellular immunity in urologic neoplasms].

Zeitschrift fur Urologie und Nephrologie, 1979
Apart from a purely qualitative evidence concerning the presence of a specific sensibilisation it is possible to estimate also its strength or the blocking factors appearing in the serum of tumour carriers by means of the electrophoresis mobility test. By this it seems to be possible to make an evidence concerning the immunological reaction position of
M, Seyfarth   +6 more
openaire   +1 more source

[The chemotherapy of urologic neoplasms].

Helvetica chirurgica acta, 1978
The newest aspects for the use of cytostatic agents in the treatment of bladder, prostatic and testicular carcinomas are presented. Especially the two new drugs diaminodichlor cisplatinum and adriamycin are discussed as to their potential use in these diseases.
openaire   +1 more source

Concurrent Abdominal Aortic Aneurysm and Urologic Neoplasm: An Argument for Simultaneous Intervention

Annals of Vascular Surgery, 1995
This report describes the surgical management of 24 patients with concurrent abdominal aortic aneurysm (AAA) and urinary tract neoplasm. The patient population consisted of 22 men and two women whose average age was 65.5 years. AAA sizes ranged from 3.1 to 9.0 cm (mean 5.2 cm) in diameter.
D A, Ginsberg   +7 more
openaire   +2 more sources

[Advance in the immunologic study of urologic neoplasms].

Archivos espanoles de urologia, 1980
The reduction of the levels of circulating T lymphocytes in urological neoplasias seems obvious. The existence of a link between the different, neoplastic, bladder and prostate processes, as well as the degree of malignancy, prognosis and therapeutic response has still to be established, according to the immunitary state of the patients.
F, Pérez Herrero   +3 more
openaire   +1 more source

[Clinical and urological after care in gynecologic neoplasms].

Fortschritte der Medizin, 1979
Patients after operative and/or radiological therapy for cervical cancer should have gynecological follow-up examinations every two months in the first year. In cases of urological complications after irradiation therapy, radionephrography, infusion urogram, blood count, cystoscopy, and cystometry should also be carried out after two months.
S, Havlicek, L, Kos
openaire   +1 more source

Home - About - Disclaimer - Privacy